These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 15520276

  • 1. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.
    Matheu A, Pantoja C, Efeyan A, Criado LM, Martín-Caballero J, Flores JM, Klatt P, Serrano M.
    Genes Dev; 2004 Nov 15; 18(22):2736-46. PubMed ID: 15520276
    [Abstract] [Full Text] [Related]

  • 2. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
    Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A.
    Nature; 2001 Sep 06; 413(6851):83-6. PubMed ID: 11544530
    [Abstract] [Full Text] [Related]

  • 3. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG.
    Cancer Res; 2003 Jun 15; 63(12):3395-402. PubMed ID: 12810676
    [Abstract] [Full Text] [Related]

  • 4. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE, Ramsey MR, Balasubramanian P, Castrillon DH, DePinho RA.
    Oncogene; 2004 Jan 15; 23(2):379-85. PubMed ID: 14724566
    [Abstract] [Full Text] [Related]

  • 5. Anti-aging activity of the Ink4/Arf locus.
    Matheu A, Maraver A, Collado M, Garcia-Cao I, Cañamero M, Borras C, Flores JM, Klatt P, Viña J, Serrano M.
    Aging Cell; 2009 Apr 15; 8(2):152-61. PubMed ID: 19239418
    [Abstract] [Full Text] [Related]

  • 6. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Uhrbom L, Kastemar M, Johansson FK, Westermark B, Holland EC.
    Cancer Res; 2005 Mar 15; 65(6):2065-9. PubMed ID: 15781613
    [Abstract] [Full Text] [Related]

  • 7. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L, Dai C, Celestino JC, Rosenblum MK, Fuller GN, Holland EC.
    Cancer Res; 2002 Oct 01; 62(19):5551-8. PubMed ID: 12359767
    [Abstract] [Full Text] [Related]

  • 8. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y, Zhang Z, Kastens E, Lubet RA, You M.
    Cancer Res; 2003 Aug 01; 63(15):4389-95. PubMed ID: 12907609
    [Abstract] [Full Text] [Related]

  • 9. p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
    Sharpless NE, Alson S, Chan S, Silver DP, Castrillon DH, DePinho RA.
    Cancer Res; 2002 May 15; 62(10):2761-5. PubMed ID: 12019151
    [Abstract] [Full Text] [Related]

  • 10. Spectral karyotyping of sarcomas and fibroblasts derived from Ink4a/Arf-deficient mice reveals chromosomal instability in vitro.
    Robertson SA, Schoumans J, Looyenga BD, Yuhas JA, Zylstra CR, Koeman JM, Swiatek PJ, Teh BT, Williams BO.
    Int J Oncol; 2005 Mar 15; 26(3):629-34. PubMed ID: 15703817
    [Abstract] [Full Text] [Related]

  • 11. Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice.
    Martín-Caballero J, Flores JM, García-Palencia P, Collado M, Serrano M.
    Oncogene; 2004 Oct 28; 23(50):8231-7. PubMed ID: 15378017
    [Abstract] [Full Text] [Related]

  • 12. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.
    Gadd M, Pisc C, Branda J, Ionescu-Tiba V, Nikolic Z, Yang C, Wang T, Shackleford GM, Cardiff RD, Schmidt EV.
    Cancer Res; 2001 Dec 15; 61(24):8811-9. PubMed ID: 11751403
    [Abstract] [Full Text] [Related]

  • 13. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ, Bertwistle D, DEN Besten W, Kuo ML, Sugimoto M, Tago K, Williams RT, Zindy F, Roussel MF.
    Cold Spring Harb Symp Quant Biol; 2005 Dec 15; 70():129-37. PubMed ID: 16869746
    [Abstract] [Full Text] [Related]

  • 14. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.
    Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW, DePinho RA.
    Nature; 2001 Sep 06; 413(6851):86-91. PubMed ID: 11544531
    [Abstract] [Full Text] [Related]

  • 15. A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression.
    Zhang Z, Wang Y, Herzog CR, Liu G, Lee HW, DePinho RA, You M.
    Oncogene; 2002 Aug 29; 21(38):5960-6. PubMed ID: 12185599
    [Abstract] [Full Text] [Related]

  • 16. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo.
    Takeuchi S, Takahashi A, Motoi N, Yoshimoto S, Tajima T, Yamakoshi K, Hirao A, Yanagi S, Fukami K, Ishikawa Y, Sone S, Hara E, Ohtani N.
    Cancer Res; 2010 Nov 15; 70(22):9381-90. PubMed ID: 21062974
    [Abstract] [Full Text] [Related]

  • 17. Ink4a/Arf links senescence and aging.
    Sharpless NE.
    Exp Gerontol; 2004 Nov 15; 39(11-12):1751-9. PubMed ID: 15582292
    [Abstract] [Full Text] [Related]

  • 18. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P, Zaravinos A, Zioga M, Spandidos DA.
    Br J Dermatol; 2009 Jun 15; 160(6):1215-21. PubMed ID: 19298278
    [Abstract] [Full Text] [Related]

  • 19. The regulation of INK4/ARF in cancer and aging.
    Kim WY, Sharpless NE.
    Cell; 2006 Oct 20; 127(2):265-75. PubMed ID: 17055429
    [Abstract] [Full Text] [Related]

  • 20. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 20; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.